We speak at a number of industry events and conferences throughout the year.
- 8:30 a.m. (EST) / 1:30 p.m. (GMT)
- George Tziras, CEO, and Dr. Carol Routledge, CMSO
Small Pharma to discuss results of SPL026 Phase IIa trial for Major Depressive Disorder and host conference call on Wednesday, January 25
Our management team will host a conference call to discuss the topline results from our Phase IIa trial of SPL026 in Major Depressive Disorder.
Conference Call and Webcast Details:
Dial-in number (from US): +1-877-423-9813
Dial-in number (from outside US):+1-201-689-8573
Conference ID: 13735973
Webcast (to view presentation slides): https://viavid.webcasts.com/starthere.jsp?ei=1595427&tp_key=af827d4034